Greater Cannabis Company (GCAN) Accounts Payables (2017 - 2026)
Greater Cannabis Company (GCAN) recorded quarterly Accounts Payables of $7514.0 in Q1 2026, down 11.75% quarter-over-quarter from $8514.0 in Q4 2025, and down 6.59% on a YoY basis from $8044.0 in Q1 2025.
Greater Cannabis Company (GCAN) Accounts Payables (2017 - 2026) Analysis & Trends
Greater Cannabis Company's Accounts Payables history runs 10 years deep, the most recent figure standing at $7514.0 for Q1 2026.
- In Q1 2026, Accounts Payables fell 6.59% year-over-year to $7514.0; the TTM figure through Mar 2026 stood at $7514.0 (down 6.59% YoY), while the FY2025 annual figure was $8514.0, up 8.06% from the prior year.
- Accounts Payables was $7514.0 for Q1 2026 at Greater Cannabis Company, down from $8514.0 in the prior quarter.
- In the past five years, Accounts Payables ranged from a high of $16251.0 in Q4 2022 to a low of $3340.0 in Q3 2023.
- Historically, Accounts Payables has averaged $8126.2 across 5 years, with a median of $7514.0 in 2026.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables surged 333.56% in 2022, then slumped 76.64% in 2023.
- A 5-year view of Accounts Payables shows it stood at $16251.0 in 2022, then sank by 62.5% to $6094.0 in 2023, then increased by 29.29% to $7879.0 in 2024, then increased by 8.06% to $8514.0 in 2025, then slipped by 11.75% to $7514.0 in 2026.
- The last three Accounts Payables figures came in at $7514.0 (Q1 2026), $8514.0 (Q4 2025), and $8849.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 2.60 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 507.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 498.30 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 48.78 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 773.00 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 372.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 102.36 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 306.87 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 45.88 Mn |
| 10 | Greater Cannabis Company | - | - | - | 7,514.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7,514.00 |
| Dec 31, 2025 | 8,514.00 |
| Sep 30, 2025 | 8,849.00 |
| Jun 30, 2025 | 6,793.00 |
| Mar 31, 2025 | 8,044.00 |
| Dec 31, 2024 | 7,879.00 |
| Sep 30, 2024 | 6,418.00 |
| Jun 30, 2024 | 5,259.00 |
| Mar 31, 2024 | 6,259.00 |
| Dec 31, 2023 | 6,094.00 |
| Sep 30, 2023 | 3,340.00 |
| Jun 30, 2023 | 5,340.00 |
| Mar 31, 2023 | 5,993.00 |
| Dec 31, 2022 | 16,251.00 |
| Sep 30, 2022 | 14,297.00 |
| Jun 30, 2022 | 8,346.00 |
| Mar 31, 2022 | 12,955.00 |
| Dec 31, 2021 | 11,705.00 |
| Sep 30, 2021 | 8,442.00 |
| Jun 30, 2021 | 1,925.00 |